We also observed that significantly different mutation frequencies in SLK, OTOP1, MYO1F, MYH3, FANCM, CSF2RA, ATP7A, and ANK3, while further studies were needed to explore their roles in glioma. This evidence concerns the gene ATP7A and central nervous system cancer.